News

Serologic Interference with Anti-CD38 Therapy in Multiple Myeloma Patients

3/1/2016

Daratumumab (i.e. DARZALEX™ or DARA), from Janssen Biotech (Johnson & Johnson), is a new drug recently approved by the FDA …

Read more

IRL uses Capture-P Platelet Antibody Screen

1/1/2016

IRL Replaces PakPlus Platelet Antibody Detection Assay with Capture-P Platelet Antibody Screen Effective January 1, 2016 the Immunohematology Reference Laboratory …

Read more

Vitalant encounters rare case of acute hemolytic transfusion reaction to anti-Leb

11/12/2015

Vitalant encounters rare case of acute hemolytic transfusion reaction to anti-Leb in 30-year old African-American woman being treated for cancer. …

Read more

BSL to Present Poster at AABB on a Mimicking Autoantibody in an Antigen Negative Individual

8/3/2015

Vitalant has been selected to present a poster at the 2015 AABB Annual Meeting in Anaheim, October 24- 27. Dolores …

Read more

BSI/BSRI on Host Team for Cellular Therapies in Trauma and Critical Care Medicine: Forging New Frontiers, San Francisco, September 25-26, 2015

5/7/2015

BSI/BSRI on host team for Cellular Therapies in Trauma and Critical Care Medicine: Forging New Frontiers, San Francisco, September 25-26, …

Read more

BSL Selected to Present Poster at ISCT 2015

4/7/2015

BSL selected to present poster at ISCT 2015: Defining the Translational Pathway from Research to Clinical-grade Stromal Mesenchymal Stem Cell …

Read more

Vitalant Collaborative Group to Study New Area of Cellular Therapy

1/29/2014

Vitalant and Vitalant Research Institute (BSRI) are part of a new collaborative group that is studying whether certain stem cells …

Read more